Myasthenia gravis is an autoimmune disorder that causes muscle weakness and fatigue due to antibodies targeting the acetylcholine receptor (AChR), muscle-specific kinase (MuSK), or related proteins at the neuromuscular junction; traditional treatments, like acetylcholinesterase inhibitors, corticosteroids, and immunosuppressants, are effective but have significant long-term side effects.
Read More > https://raredisease.pocn.com/treatment/molecular-therapies-offer-new-hope-for-myasthenia-gravis-treatment/
